Ray Dalio’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $680K | Sell |
3,471
-47
| -1% | -$9.13K | ﹤0.01% | 848 |
|
|
2025
Q4 | $610K | Sell |
3,518
-2,128
| -38% | -$387K | ﹤0.01% | 947 |
|
|
2025
Q3 | $1.08M | Buy |
5,646
+1,875
| +50% | +$333K | ﹤0.01% | 843 |
|
|
2025
Q2 | $677K | Sell |
3,771
-25,497
| -87% | -$4.43M | ﹤0.01% | 500 |
|
|
2025
Q1 | $4.95M | Buy |
29,268
+7,378
| +34% | +$1.21M | 0.02% | 359 |
|
|
2024
Q4 | $3.3M | Sell |
21,890
-66,849
| -75% | -$10.4M | 0.02% | 400 |
|
|
2024
Q3 | $13.8M | Sell |
88,739
-54,979
| -38% | -$8.21M | 0.08% | 212 |
|
|
2024
Q2 | $19.7M | Sell |
143,718
-54,083
| -27% | -$7.41M | 0.1% | 154 |
|
|
2024
Q1 | $26.3M | Sell |
197,801
-3,799
| -2% | -$493K | 0.13% | 122 |
|
|
2023
Q4 | $27.8M | Sell |
201,600
-44,452
| -18% | -$5.84M | 0.16% | 105 |
|
|
2023
Q3 | $30M | Buy |
246,052
+106,639
| +76% | +$14.2M | 0.18% | 96 |
|
|
2023
Q2 | $19.6M | Sell |
139,413
-9,108
| -6% | -$1.26M | 0.12% | 134 |
|
|
2023
Q1 | $21M | Sell |
148,521
-46,502
| -24% | -$6.65M | 0.13% | 135 |
|
|
2022
Q4 | $30.5M | Buy |
195,023
+33,728
| +21% | +$4.85M | 0.17% | 116 |
|
|
2022
Q3 | $19.8M | Sell |
161,295
-13,962
| -8% | -$1.84M | 0.1% | 156 |
|
|
2022
Q2 | $23.3M | Buy |
175,257
+4,220
| +2% | +$575K | 0.1% | 178 |
|
|
2022
Q1 | $23.4M | Buy |
171,037
+29,631
| +21% | +$4.13M | 0.09% | 157 |
|
|
2021
Q4 | $24.5M | Buy |
141,406
+8,794
| +7% | +$1.34M | 0.14% | 114 |
|
|
2021
Q3 | $19.3M | Buy |
132,612
+3,800
| +3% | +$556K | 0.11% | 130 |
|
|
2021
Q2 | $17M | Buy |
128,812
+66,636
| +107% | +$8.72M | 0.11% | 145 |
|
|
2021
Q1 | $7.98M | Sell |
62,176
-5,567
| -8% | -$686K | 0.07% | 184 |
|
|
2020
Q4 | $8.07M | Buy |
67,743
+34,860
| +106% | +$4.25M | 0.07% | 149 |
|
|
2020
Q3 | $3.77M | Buy |
32,883
+28,005
| +574% | +$3.31M | 0.05% | 166 |
|
|
2020
Q2 | $556K | Sell |
4,878
-2,422
| -33% | -$257K | 0.01% | 243 |
|
|
2020
Q1 | $586K | Buy |
+7,300
| New | +$756K | 0.01% | 270 |
|
|
2019
Q3 | – | Sell |
-34,817
| Closed | -$3.54M | – | 346 |
|
|
2019
Q2 | $3.54M | Sell |
34,817
-19,541
| -36% | -$1.88M | 0.03% | 164 |
|
|
2019
Q1 | $4.89M | Sell |
54,358
-87,368
| -62% | -$7.57M | 0.03% | 140 |
|
|
2018
Q4 | $11.8M | Buy |
141,726
+108,465
| +326% | +$10.2M | 0.11% | 106 |
|
|
2018
Q3 | $3.59M | Buy |
33,261
+6,706
| +25% | +$736K | 0.04% | 143 |
|
|
2018
Q2 | $2.92M | Sell |
26,555
-92,574
| -78% | -$9.64M | 0.03% | 172 |
|
|
2018
Q1 | $11.9M | Buy |
119,129
+98,569
| +479% | +$10.1M | 0.11% | 54 |
|
|
2017
Q4 | $2.02M | Sell |
20,560
-187,561
| -90% | -$17.8M | 0.02% | 159 |
|
|
2017
Q3 | $19.5M | Buy |
+208,121
| New | +$22.1M | 0.13% | 34 |
|
|
2016
Q1 | – | Sell |
-64,399
| Closed | -$4.58M | – | 271 |
|
|
2015
Q4 | $4.58M | Sell |
64,399
-172,193
| -73% | -$11.6M | 0.06% | 126 |
|
|
2015
Q3 | $14.5M | Buy |
236,592
+166,203
| +236% | +$11.6M | 0.19% | 42 |
|
|
2015
Q2 | $5.11M | Sell |
70,389
-77,699
| -52% | -$5.74M | 0.05% | 101 |
|
|
2015
Q1 | $11.4M | Buy |
148,088
+94,962
| +179% | +$6.8M | 0.09% | 52 |
|
|
2014
Q4 | $3.56M | Buy |
53,126
+37,500
| +240% | +$2.37M | 0.03% | 149 |
|
|
2014
Q3 | $948K | Buy |
15,626
+2,081
| +15% | +$128K | 0.01% | 224 |
|
|
2014
Q2 | $795K | Sell |
13,545
-65,432
| -83% | -$3.83M | 0.01% | 238 |
|
|
2014
Q1 | $4.57M | Buy |
+78,977
| New | +$4.23M | 0.04% | 112 |
|
|
2013
Q3 | – | Sell |
-4,598
| Closed | -$279K | – | 333 |
|
|
2013
Q2 | $279K | Buy |
+4,598
| New | +$274K | ﹤0.01% | 295 |
|
Other funds holding DGX
VCM
VPM
EIG
Ray Dalio's DGX Position: Q1 2026 in Review
Ray Dalio reduced its Quest Diagnostics (DGX) stake by 1.3% in Q1 2026, selling an estimated $9.13K and leaving 3,471 shares worth $680K. The position accounts for ﹤0.01% of the portfolio, ranked #848.
Ray Dalio first reported a position in DGX in Q2 2013 and has held it in 42 quarters since. The position peaked at $30.5M in Q4 2022. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Ray Dalio held 3,471 shares of Quest Diagnostics worth $680K as of Q1 2026.
- Ray Dalio sold 47 Quest Diagnostics shares in Q1 2026, an estimated $9.13K.
- Quest Diagnostics made up ﹤0.01% of Ray Dalio's portfolio in Q1 2026, its #848 holding.
- Ray Dalio first reported a position in Quest Diagnostics in Q2 2013 and has held it in 42 quarters since.
- Ray Dalio's Quest Diagnostics position peaked at $30.5M in Q4 2022.
- 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.